We are live on
!
Find out more
Chevy Chase Trust Portfolio holdings
AUM
$34.7B
1-Year Est. Return
29.45%
This Fund
S&P 500
This Quarter
Est. Return
+22.49%
1 Year Est. Return
+29.45%
3 Year Est. Return
+102.04%
5 Year Est. Return
+142.29%
10 Year Est. Return
+525.93%
AUM
$24.7B
AUM Growth
+$3.17B
(+15%)
Cap. Flow
-$1.16B
Cap. Flow
% of AUM
-4.72%
Top 10 Holdings %
Top 10 Hldgs %
26.96%
Holding
661
New
31
Increased
56
Reduced
513
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$73.5M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$27.2M |
| 3 |
DexCom
DXCM
|
+$26.6M |
| 4 |
T-Mobile US
TMUS
|
+$18.9M |
| 5 |
ASML
ASML
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$87.1M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$80.5M |
| 3 |
Microsoft
MSFT
|
+$75.5M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$54.8M |
| 5 |
AGN
Allergan plc
AGN
|
+$49.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.84% |
| 4 | Communication Services | 10.4% |
| 5 | Consumer Discretionary | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Las Vegas Sands
LVS
$29.4B
| $12.3M | 0.05% |
270,411
-16,853
| -6% | -$792K |
|
327
Cardinal Health
CAH
$55.6B
| $12.3M | 0.05% |
235,009
-13,623
| -5% | -$702K |
|
328
CBRE Group
CBRE
$41.7B
| $12.2M | 0.05% |
269,737
-14,820
| -5% | -$639K |
|
329
Cencora
COR
$62B
| $12.1M | 0.05% |
120,351
-8,277
| -6% | -$762K |
|
330
Essex Property Trust
ESS
$18.2B
| $12.1M | 0.05% |
52,640
-3,532
| -6% | -$847K |
|
331
Paycom
PAYC
$9.63B
| $12M | 0.05% |
38,867
-2,881
| -7% | -$767K |
|
332
Oneok
OKE
$56.9B
| $12M | 0.05% |
359,925
+11,044
| +3% | +$360K |
|
333
Healthpeak Properties
DOC
$14.4B
| $11.9M | 0.05% |
433,144
+12,408
| +3% | +$317K |
|
|
HOLX
334
DELISTED
Hologic
HOLX
| $11.9M | 0.05% |
208,578
-14,679
| -7% | -$720K |
|
335
Dover
DOV
$28.3B
| $11.9M | 0.05% |
122,728
-7,632
| -6% | -$705K |
|
336
CarMax
KMX
$8.34B
| $11.7M | 0.05% |
130,995
-5,542
| -4% | -$434K |
|
337
Domino's
DPZ
$11.5B
| $11.7M | 0.05% |
+31,588
| New | +$11.6M |
|
338
Broadridge
BR
$19.8B
| $11.7M | 0.05% |
92,392
-5,064
| -5% | -$586K |
|
|
KSU
339
DELISTED
Kansas City Southern
KSU
| $11.5M | 0.05% |
76,973
-7,783
| -9% | -$1.09M |
|
|
GRMN
340
Garmin
GRMN
$60.4B
| $11.4M | 0.05% |
116,850
-5,964
| -5% | -$510K |
|
341
Jack Henry & Associates
JKHY
$11B
| $11.3M | 0.05% |
61,659
-3,743
| -6% | -$652K |
|
342
Cooper Companies
COO
$14.9B
| $11.2M | 0.05% |
158,528
-10,372
| -6% | -$769K |
|
343
International Paper
IP
$21.9B
| $11.1M | 0.05% |
334,096
-18,111
| -5% | -$577K |
|
344
Hartford Financial Services
HIG
$38.7B
| $11.1M | 0.05% |
288,790
-18,268
| -6% | -$696K |
|
345
Tyler Technologies
TYL
$13.1B
| $11.1M | 0.05% |
+32,031
| New | +$10.7M |
|
|
FITB
346
Fifth Third Bancorp
FITB
$51.8B
| $11.1M | 0.04% |
573,518
-30,383
| -5% | -$563K |
|
347
Ventas
VTR
$47.2B
| $11M | 0.04% |
300,212
-17,539
| -6% | -$579K |
|
348
Zebra Technologies
ZBRA
$17.9B
| $11M | 0.04% |
42,938
-3,108
| -7% | -$728K |
|
349
M&T Bank
MTB
$36.3B
| $11M | 0.04% |
105,620
-9,329
| -8% | -$985K |
|
350
W.W. Grainger
GWW
$61.1B
| $11M | 0.04% |
34,891
-2,219
| -6% | -$641K |
|
Similar funds
VIA
SAM
Chevy Chase Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Chevy Chase Trust held 661 positions worth $24.7B, up 15% from $21.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Chevy Chase Trust withdrew a net $1.16B in Q2 2020, closing 20 positions and reducing 513 holdings. Its most notable exit was Allergan plc, an estimated $49.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Chevy Chase Trust opened a new position in DexCom worth $30.1M.
- Chevy Chase Trust's largest Q2 2020 buy was DexCom: 297,088 shares worth $30.1M.
- Chevy Chase Trust added most to RTX Corp in Q2 2020, an estimated $73.5M increase.
- Chevy Chase Trust's biggest Q2 2020 reduction was Apple, cutting an estimated $87.1M.
- Chevy Chase Trust fully exited Allergan plc in Q2 2020, selling an estimated $49.5M.
- Chevy Chase Trust's ten largest holdings make up 27% of its $24.7B portfolio in Q2 2020.
- Chevy Chase Trust opened 31 new positions and closed 20 in Q2 2020.
- Chevy Chase Trust's portfolio value rose 15% quarter-over-quarter to $24.7B.
Based on Chevy Chase Trust's 13F filing for Q2 2020, filed 14 Aug 2020.